Literature DB >> 19372080

Acute hemolysis caused by incidental trichlorfon exposure.

Ming-Ling Wu1, Jou-Fang Deng.   

Abstract

Trichlorfon (o-o-dimethyl-2,2,2-trichloro-hydroxyethylphosphate), an organophosphate, has a moderately potent anticholinesterase activity. Organophosphate poisoning is well known for its characteristic symptoms and signs, but acute hemolysis caused by trichlorfon is rarely reported. We present a patient who developed acute hemolysis and renal function impairment after percutaneous trichlorfon exposure. A 54-year-old man applied trichlorfon powder to his dog to kill its parasites. Half an hour later, the dog was suspected to die of cholinergic crisis and the patient felt abdominal cramping pain. Later, he developed severe nausea, vomiting, chills, high fever, and cold sweat. Laboratory work-up disclosed a picture of acute hemolysis, jaundice, renal function impairment and leukocytosis. However, there were no clinical features of acute cholinergic syndrome except gastrointestinal symptoms, and blood cholinesterase activities were also normal. He eventually had a full recovery. Trichlorfon should be added to the toxins known to cause acute hemolysis.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19372080     DOI: 10.1016/S1726-4901(09)70058-9

Source DB:  PubMed          Journal:  J Chin Med Assoc        ISSN: 1726-4901            Impact factor:   2.743


  3 in total

Review 1.  Organophosphorus pesticide determination in biological specimens: bioanalytical and toxicological aspects.

Authors:  Sofia Soares; Tiago Rosado; Mário Barroso; Duarte Nuno Vieira; Eugenia Gallardo
Journal:  Int J Legal Med       Date:  2019-07-12       Impact factor: 2.686

2.  Unusual complications of quinalphos poisoning.

Authors:  Stalin Viswanathan
Journal:  Case Rep Emerg Med       Date:  2013-05-12

3.  Black Coloured Urine following Organophosphorus Poisoning: Report of Two Cases.

Authors:  Aneesh Basheer; Sudhagar Mookkappan; Vijay Shanmugham; Nagarajan Natarajan; Kiran Kulirankal
Journal:  Case Rep Crit Care       Date:  2014-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.